The relationship of exposure to amphetamines and malignant lymphoma was evaluated using data collected by the Boston Collaborative Drug Surveillance Program. Of the 315 patients with this diagnosis, none gave a history of exposure to amphetamines, while among 38,900 control subjects 218 (0.56%) gave such a history. These findings do not lend support to the recently published hypothesis of an association between amphetamine usage and Hodgkin disease.
(JAMA 229:1462-1463, 1974)
Amphetamines and Malignant LymphomaA Report From the Boston Collaborative Drug Surveillance Program. JAMA. 1974;229(11):1462–1463. doi:10.1001/jama.1974.03230490050023